Release of the aspartyl protease cathepsin D is associated with and facilitates human breast cancer cell invasion

FASEB Journal

Volumn 11, Issue 10, 1997, Pages 785-792

  Tedone, Teresa ^a   Correale, Mario ^a   Barbarossa, Grazia ^a   Casavola, Valeria ^b   Paradiso, Angelo ^a   Reshkin, Stephan J ^a,b  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

MCF 7; Proliferation; Protease

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ASPARTIC PROTEINASE; CATHEPSIN D; ENZYME INHIBITOR; ESTRADIOL;

ARTICLE; BREAST CANCER; CANCER CELL; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME RELEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SERUM;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0030872194     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.11.10.9271363     Document Type: Article

References (36)

1. Aznavoorian S., Murphy, A. N., Stetler-Stevenson, W. G., and Liotta, L. A. (1993) Molecular aspects of tumor cell invasion and metastasis. Cancer 71, 1368-1383
2. Duffy M. J. (1992) The role of proteolytic enzymes in cancer invasion and metastasis. Clin. Exp. Metastasis 10, 145-155
3. Mignatti, P., and Rifkin, D. B. (1993) Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73, 161-195
4. Rochefort, H. (1992) Biological and clinical significance of cathepsin D in breast cancer. Acta Oncol. 31, 125-130
5. Westly, B. R., and May, F. E. B. (1996) Cathepsin D and breast cancer. Eur. J. Cancer 32A, 15-24
6. Ravdin, P. M. (1993) Evaluation of cathepsin D as a prognostic factor in breast cancer. Breast Cancer Res. Treatment 24, 219-226
7. Schultz, D. C., Bazel, S., Wright, L. M., Tucker, S., Lange, M. K., Tachovsky, T., Longo, S., Niedbala, S., and Alhadeff, J. A. (1994) Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease. Cancer Res. 54, 48-54
8. Tanaka, K., and Ichihara, A. (1976) Effect of the growth state on protein turnover in L cells. Exp. Cell Res. 99, 1-6
9. Lockwood, T. D., and Shier, W. T. (1977) Regulation of acid proteases during growth, quiescence and starvation in normal and transformed cells. Nature (London) 267, 252-254
10. Vignon, F., Capony, F., Chambon, M., Freiss, G., Garcia, M., and Rochefort, H. (1986) Autocrine growth stimulation of the MCF7 breast-cancer cells by the estrogen-regulated 52K protein. Endocrinology 118, 1537-1542
11. Vetvicka, V., Vektvickova, J., and Fusek, M. (1994) Effect of human procathepsin D on proliferation of human cell lines. Cancer Lett. 79, 131-135
12. Isidoro, C., Demoz, M., DeStefanis, D., Baccino, F. M., and Bonelli, G. (1995) Synthesis, maturation and extracellular release of procathepsin D as influenced by cell proliferation or transformation. Int. J. Cancer 63, 866-871
13. Cavailles, V., Augereau, P., Garcia, M., and Rochefort, H. (1988) Estrogens and growth factors induce mRNA of pro-cathepsin D secreted by breast cancer cells. Nucl. Acid Res. 16, 1903-1919
14. Cavailles, V., Garcia, M., and Rochefort, H. (1989) Regulation of cathepsin D and pS2 gene expression by growth factors in MCF-7 human breast cancer cells. Mol. Endocr. 3, 552-558
15. Johnson, M. D., Torri, J. A., Lippman, M. E., and Dickson, R. B. (1993) The role of cathepsin D in the invasiveness of human breast cancer cells. Cancer Res. 53, 873-877
16. Garcia, M., Derocq, D., Pujol, P., and Rochefort, H. (1990) Over-expression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene 5, 1809-1814
17. Thompson, E. W., Brunner, N., Torri, J., Johnson, M. D., Boulay, V., Wright, A., Lippman, M. E., Steeg, P., and Clarke, R. (1993) The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF7 human breast cancer cells. Clin. Esp. Metastasis 11, 15-26
18. Soule, H. D., Vasquez, J., Long, A., Albert, S., and Brennan, M. (1973) A human cell line from a pleural effusion from a breast carcinoma. J. Natl. Cancer Inst. 51, 1409-1413
19. Tedone T., Correale, M., Paradiso A., and Reshkin, S. J. (1996) Differential responsiveness of proliferation and cytokeratin release to stripped serum and estrogen in the human breast cancer cell line, MCF-7. Eur. J. Cancer 32A, 849-856
20. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aaronson, S. A., Kozlowski, J. M., and McEwan, R. N. (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47, 3239-3245
21. Richardson, J.M., Woychick, N. A., Ebert, D. L., Dimond, R. L., and Cardelli, J. A. (1988) Inhibition of early but not late proteolytic processing events leads to the missorting and oversecretion of precursor forms of lysomal enzymes in Dictyostelium discoideum. J. Cell Biol. 107, 2097-2107
22. Augereau, P., Garcia, M., Mattei, M. G., Cavailles, V., Depadova, F., Derocq, D., Capony, F., Ferrara, P., and Rochefort, H. (1988) Cloning and sequencing of the 52K. cathepsin D complementary deoxyriboucleic acid of MCF-7 breast cancer cells and mapping on chromosome 11. Mol. Endoctrinol. 2, 186-192
23. Genetics Computer Group. (1994) Program manual for GSG Package. 595 Science Drive, Madison, Wisconsin, 53711, USA
24. Capaccioli, S., Di Pasquale, G., Mini, E., Mazzei, T., and Quattrone, A. (1993) Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum. Biochem. Biophys. Res. Commun. 197, 818-825
25. Westly, B. R., and Rochefort, H. (1979) Estradiol induced proteins in the MCF-7 human cancer cell line. Biochem. Biophys. Res. Commun. 90, 410-416
26. Pagliacci, M. C., Tognellini, R., Grignani, F., and Nicoletti, I. (1991) Inhibition of human breast cancer cell (MCF-7) growth in vitro by the somatostatin analog SMS 201-995: Effects on cell cycle parameters and apoptotic cell death. Endocrinology 129, 2555-2562
27. Slone, B. F. (1990) Cathepsin B and cystatins: evidence for a role in cancer progression. In: Seminars in Cancer Biology, Vol. 1, pp. 137-152, W. B. Saunders Co., Philadelphia
28. Briozzo, P., Morisset, M., Capony, F., Rougeot, C., and Rochefort, H. (1988) In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res. 48, 3688-3692
29. Briozzo, P., Badet, J., Capony, F., Pieri, I., Montcourrier, P., Barritault, D., and Rochefort, H. (1991) MCF-7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp. Cell Res. 194, 252-259
30. Gonover, C. A. and DeLeon, D. D. (1994) Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells. Role of cathepsin D. J. Biol. Chem. 269, 7076-7080
31. Helseth, D. L., Jr., and Veis, A. (1984) Cathepsin D-mediated processing of procollagen: lysosomal enzyme involvement in secretory processing of procollagen. Proc. Natl. Acad. Sci. USA 81, 3302-3311
32. Tannock, I. F., and Rotin, D. (1989) Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 49, 4373-4384
33. 31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate. Am. J. Physiol. 267, C195-C203
34. Frelin, C., Vigne, P., Ladoux, A., and Lazdunski, M. (1988) The regulation of the intracellular pH in cell from vertebrates. Eur. J. Biochem. 174, 3-14
35. Martinez-Zaguilan, R., Lynch, R. M., Martinez, G. A., and Gillies, R. J. (1993) Vacuolar-type H+-ATPases are functionally expressed in plasma membranes of human tumor cells. Am. J. Physiol. 265, C1015-C1029
36. Rozhin, J., Sameni, M., Ziegler, G., and Slone, B. F. (1994) Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res. 54, 6517-6525